
Health insurers promise to improve coverage reviews that prompt delays and complaints
UnitedHealthcare, CVS Health's Aetna and dozens of other insurers say they plan to reduce the scope of health care claims subject to prior authorization, standardize parts of the process and expand responses done in real time.
Prior authorization means insurers require approval before they'll cover medical care, a prescription or a service like an imaging exam. Insurers say they do this to guard against care overuse and to make sure patients get the right treatment.
But doctors say the practice has grown in scope and complication, leading to frequent care delays. The fatal shooting of UnitedHealthcare CEO Brian Thompson in December prompted many people to vent their frustrations with coverage issues like prior authorization.
Dr. Mehmet Oz called prior the practice 'a pox on the system' that hikes administrative costs during his Senate confirmation hearing in March to lead the Centers for Medicare and Medicaid Services.
Insurers said Monday that they will standardize electronic prior authorization by the end of next year to help speed up the process. They will reduce the scope of claims subject to medical prior authorization, and they will honor the pre-approvals of a previous insurer for a window of time after someone switches plans.
They also plan to expand the number of real-time responses and ensure medical reviews are done for denied requests.
'We're sort of trapped between care being unaffordable and then these non-financial barriers and administrative burdens growing worse,' said Michael Anne Kyle, an assistant professor at the University of Pennsylvania who studies how patients access care.
Nearly all customers of Medicare Advantage plans, the privately run version of the federal government's Medicare program, need prior authorization for some services, particularly expensive care like hospital stays, the health policy research organization KFF found in a study of 2023 claims. The study also found that insurers denied about 6% of all requests.
Dr. Ashley Sumrall of Charlotte, North Carolina, says she has seen an increase in prior authorizations required for routine exams like MRIs. An oncologist who treats brain tumors, Sumrall said these images are critical for doctors to determine whether a treatment is working and to plan next steps.
Doctors say delays from requests that are eventually approved or coverage rejections can harm patients by giving a disease time to progress untreated. They also can spike anxiety in patients who want to know whether their tumor has stopped growing and if insurance will cover the scan.
'There's a term that we use called 'scanxiety,' and it's very real,' said Sumrall, a member of the Association for Clinical Oncology's volunteer leadership.
Different forms and varied prior authorization policies also complicate the process. Sumrall noted that every insurer 'has their own way of doing business.'
'For years, the companies have been unwilling to compromise, so I think any step in the direction of standardization is encouraging,' she said.
The insurers say their promises will apply to coverage through work or the individual market as well as Medicare Advantage plans and the state and federally funded Medicaid program.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty
Elevance Health, Inc. (NYSE:ELV) ranks among the . Wells Fargo kept its Overweight rating on Elevance Health, Inc. (NYSE:ELV) on July 15, but lowered its price target on the health insurer from $478 to $400. Wells Fargo applied a lower multiple of 10.5x to its 2026 earnings per share projection of $38.05, which is less than the previous multiple of 11.5x. designer491/ Wells Fargo stated that the primary driver of the reduced value multiple was uncertainty regarding margins in the Medicaid, Medicare Advantage (MA), and Health Insurance Exchange (HIX) segments for 2025. The firm also pointed out that there was 'relatively low visibility to improvement in 2026,' especially in the Medicaid and Health Insurance Exchange segments. However, it insisted that Elevance's valuation 'remains compelling once dust settles on estimates.' Elevance Health, Inc. (NYSE:ELV), previously Anthem, Inc., is a leading health-benefits provider in the United States. The company offers medical, pharmaceutical, dental, long-term care, disability, and behavioral health insurance under numerous brands, including Anthem Blue Cross, Blue Shield, Wellpoint, and Carelon. While we acknowledge the potential of ELV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 hours ago
- Yahoo
Earnings Teleconference Moves to Earlier Time on July 29
July 25, 2025--(BUSINESS WIRE)--As previously announced, UnitedHealth Group will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the market opens. The start time for the teleconference has moved to 8:00 a.m. ET, 45 minutes earlier than previously announced, to allow more time for discussion of results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website ( The replay will be available through August 12 on the website. About UnitedHealth Group UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at and follow UnitedHealth Group on LinkedIn. View source version on Contacts Investors: investor_relations@ Media: uhgmedia@ Sign in to access your portfolio
Yahoo
21 hours ago
- Yahoo
UnitedHealth Group Stock Sinks as Company Confirms DOJ Investigations
UnitedHealth Group (UNH) on Thursday confirmed several reports in recent months that the Department of Justice is probing aspects of its business, sending shares lower in recent trading. The company said it has "proactively reached out to the Department of Justice after reviewing media reports about investigations into certain aspects of the Company's participation in the Medicare program," and is now "complying with formal criminal and civil requests from the Department." The health insurer's stock has been battered by a number of reports this year that authorities are investigating UnitedHealth's Medicare Advantage program. The company has denied claims that it has pressured physicians to bill for certain conditions that could get it larger payouts from the government. The Department of Justice did not immediately respond to a request for comment. UnitedHealth stock also fell this year after its first-quarter results fell short of estimates and the insurer lowered its profit forecast, and after its CEO departed in May. UnitedHealth is scheduled to report earnings before the market opens next Tuesday. The health insurer's stock was down over 3% Thursday afternoon. Shares have lost more than 40% of their value this year, and in May closed at $274.35, their lowest point since early 2020. This article has been updated since it was first published to reflect more recent share price values. Read the original article on Investopedia